Delivery Order SPE2DB20D2001-SPE2DB25FPMRS
Award Date
5/13/25
Potential Completion Date
5/14/25
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $23,991.58 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 500-count packages of 4 mg Ondansetron HCL tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $2,665.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,964,524 tablets of Ondansetron HCL 4 mg, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,616.70, is for the supply of 4 mg ondansetron hydrochloride tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,581.89 contract is for the delivery of 4,568,126,790 units of the medication Ondansetron HCL 8 mg tablets. The order has a completion date of May 6, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive vehicle for supplying a wide range of...
This is a $1,167.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,149,344 units of the prescription medication Ondansetron ODT 4 mg Tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $16,421.24 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a period of performance through March 27, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $2,124.45 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg ondansetron hydrochloride tablets. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as a primary vehicle for providing...
This is a $14,374.29 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,997 units of 8 mg Ondansetron HCl tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of June 26, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,134.43 firm fixed-price delivery order is for the supply of 500 tablets of 4 mg Ondansetron HCL, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of March 27, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,294.40 firm fixed-price contract is for the supply of 4 mg Ondansetron HCL tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...